Low incidence of EGFR and HRAS mutations in cutaneous squamous cell carcinomas of a German cohort

Volume: 20, Issue: 10, Pages: 848 - 850
Published: Jul 19, 2011
Abstract
: Epidermal growth factor receptor (EGFR) is highly expressed in squamous cell carcinoma (SCC). The response of patients with lung cancer to EGFR inhibitors is significantly associated with the presence of EGFR mutations. Although these drugs have already been used for the treatment of advanced cutaneous SCC, the knowledge about EGFR mutations in this cancer is limited to one previous study in the US population. We analysed the presence of EGFR...
Paper Details
Title
Low incidence of EGFR and HRAS mutations in cutaneous squamous cell carcinomas of a German cohort
Published Date
Jul 19, 2011
Volume
20
Issue
10
Pages
848 - 850
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.